Cytoskeleton Crew Findings confirm sugar's role in helping cancers survive by changing cellular architecture.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University. Valvena, GSK Sign New R&D Collaboration Valneva to supply process development services for EB66® -based Influenza vaccines. Light Signals from Living Cells Fluorescent protein markers delivered under high pressure.Cellular 'Relief Valve' A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.Genomic Signature Shared by Five Types of Cancer National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer. Cat Stem Cell Therapy Gives Humans Hope By the time Bob the cat came to the UC Davis veterinary hospital, he had used up most of his nine lives. Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.A Better Model for Parkinson's Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.
High Throughput Screening for Identification of BMP Signaling Agonists Dr Karen Vrijens, St Jude Children's Research Hospital, speaking at European Laboratory Automation 2012.
Screening for Chemical Tools: Considerations on Compound Screening Collections, Assay Development and High-throughput Screening Dominique Audenaert, VIB - Ghent University, speaking at European Lab Automation 2012
Multi-analyte Procedures for Target Screening and Quantification of Drugs in Blood using LC-MS/MS: Possibilities and Limitations Hans Maurer, Saarland University, speaking at European Lab Automation 2012.
Sample Management and HTS: Convergent Platforms and Universal Solutions to Simplify the Integration Challenge Chris Walsh, Brooks Life Science Systems, speaking at European Lab Automation 2012
Dynamic Cell Culture for Drug Discovery: Stretching Mechanotransduction from the Lung to the Lab Dr. Sanjit Nirmalanandhan, University of Kansas Medical Center, speaking at Cell Culture 2012.
ESPRIT: High Throughput Screening for Soluble Expression Constructs of Difficult-to-express Proteins Darren Hart, European Molecular Biology Laboratory, speaking at European Lab Automation 2012
Fragment Based de novo Ligand Design: A Valuable Optimisation Tool in Fragment Based Lead Discovery Peter Johnson, University of Leeds, speaking at Discovery Chemistry Congress 2012.
Fragment-Based Drug Discovery - Getting in Shape Doris Hafenbradl, Biofocus, speaking at Discovery Chemistry Congress 2012.
The Versatility of Fragment Screening Approaches and the Application of Fragment Binding Information in Durg Discovery Stefan Geschwindner, AstraZeneca, speaking at Discovery Chemistry Congress 2012.